Company / Cash per Share
BioMarin Pharmaceutical Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$6.82
FY2025
5-year range
$3.23 / $6.82
FY2021-FY2025
Trend
+38.0%
vs FY2024
Sector context
#31 of 205
Health Care
What the data says
BioMarin Pharmaceutical's cash per share of $6.82 is higher than 85% of companies in the Health Care sector (FY2025). Cash per Share has increased for 4 consecutive years, from $3.23 in FY2021 to $6.82 in FY2025.
Based on SEC 10-K filings.
6.82 in FY2025 with a 5-year CAGR of +13.8%. Top quartile in the Health Care sector.
Improved from $4.00 to $6.82 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +20.6%
- 5-Year CAGR
- +13.8%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 205This company $6.82 Sector average $72.93
▼
-90.6% below sector average
Key checks
Key Insights
- BioMarin Pharmaceutical's cash per share has grown for 4 consecutive years.
- In FY2025, cash per share increased 38.0% year-over-year.
- Ranks #31 out of 205 companies in the Health Care sector.
- Lowest cash per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.82 | +38.0% |
| FY2024 | $4.94 | +23.4% |
| FY2023 | $4.00 | +2.9% |
| FY2022 | $3.89 | +20.4% |
| FY2021 | $3.23 | -9.5% |
| FY2020 | $3.57 | +46.8% |
| FY2019 | $2.43 | -12.2% |
| FY2018 | $2.77 | -18.5% |
| FY2017 | $3.40 | +43.8% |
| FY2016 | $2.37 | -3.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026